Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve
- PMID: 33055587
- DOI: 10.1097/SLA.0000000000004054
Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve
Abstract
Objective: To investigate the perioperative and oncologic long-term outcomes of patients with LAPC after surgical resection at a high-volume center for pancreatic surgery.
Background: The role of surgery in LAPC with arterial involvement is controversial.
Methods: We analyzed 385 consecutive patients undergoing PAR (n = 195) or PAD (n = 190) of the encased artery for LAPC between January 1, 2003 and April 30, 2019.
Results: There were 183 total pancreatectomies, 113 partial pancreatoduodenectomies, 79 distal pancreatectomies, and 10 resections for tumor recurrences, including 121 multivisceral resections and 171 venous resections. Forty-three patients (11.4%) had resectable oligometastatic disease. All of the 190 patients undergoing PAD (100%) and 95 of the 195 patients undergoing PAR (48.7%) received neoadjuvant chemotherapy. The R0 (circumferential resection margin negative) resection rate was 28%. The median hospital stay was 15 days (range: 3-236). The median survival after surgery for LAPC was 20.1 months and the overall 5-year survival rate 12.5%. In-hospital mortality was 8.8% for the entire patient cohort (n = 385). With increasing case load and growing expertise, there was a significant reduction of in-hospital mortality to 4.8% (n = 186) after 2013 (P = 0.005). The learning curve of experienced pancreatic surgeons for PAR was 15 such procedures.
Conclusion: Our data demonstrate that an arterial surgical approach is effective in LAPC with promising long-term survival. PAD after neoadjuvant treatment is safe. PAR is a technically demanding procedure and requires a high level of expertise.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors report no conflicts of interest.
Comment in
-
Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".Ann Surg. 2021 Dec 1;274(6):e882-e884. doi: 10.1097/SLA.0000000000004789. Ann Surg. 2021. PMID: 33605593 No abstract available.
-
Response to the Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".Ann Surg. 2021 Dec 1;274(6):e884-e885. doi: 10.1097/SLA.0000000000004788. Ann Surg. 2021. PMID: 33605595 No abstract available.
References
-
- Tempero MA, Malafa MP, Behrman SW, et al. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2014; 12:1083–1093.
-
- Sindelar WF. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989; 124:127–132.
-
- Fortner JG, Kim DK, Cubilla A, et al. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg 1977; 186:42–50.
-
- Alsfasser G, Leicht H, Gunster C, et al. Volume-outcome relationship in pancreatic surgery. Br J Surg 2016; 103:136–143.
-
- Kleive D, Sahakyan MA, Berstad AE, et al. Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy. Br J Surg 2017; 104:1558–1567.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous